• What's involved: Study of patients with moderate-to-severe SLE to characterize disease activity, treatment patterns, outcomes, healthcare resource utilization, and associated quality of life in the general population of moderate and severe SLE patients, and also by the type I Interferon gene expression status.
  • Take part: Open
  • Principal Investigator: Mr Peter Lanyon
Research Theme | Musculoskeletal | Open Trials

What's involved

Study of patients with moderate-to-severe SLE to characterize disease activity, treatment patterns, outcomes, healthcare resource utilization, and associated quality of life in the general population of moderate and severe SLE patients, and also by the type I Interferon gene expression status.

Principal Investigator

Mr Peter Lanyon

Take part

Open
Back to all trials

Website by Volute